Related Experiment Video
Updated: Apr 14, 2026
14:43
Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
Published on: July 18, 2020
8.7K
Development, implementation and evaluation of a medication safety programme for schoolchildren in Qatar
K J Wilby1, H M Hazi2, M A Ashour3
1Clinical Pharmacy and Practice Section, College of Pharmacy, Qatar University, Doha, Qatar. kjw@qu.edu.qa.
Summary
This study assessed medication safety needs in Qatari schoolchildren and developed a health promotion program. The program was found beneficial and recommended for wider implementation.
Area of Science:
- Pediatric Health
- Health Promotion
- Medication Safety Education
Background:
- Schoolchildren require education on safe medication practices.
- A needs assessment identified key areas for a health promotion program.
Purpose of the Study:
- To assess medication safety needs among primary schoolchildren in Qatar.
- To develop and implement a health promotion program.
- To evaluate the program's effectiveness and potential for wider adoption.
Main Methods:
- Conducted semi-structured interviews with school staff (teachers, nurses, administrators).
- Developed a 25-minute health promotion program for children aged 6-10 years.
- Evaluated the program using standardized forms by site representatives, investigators, and peer reviewers.
Main Results:
- Identified 'medication basics' and 'medication safety' as key themes from interviews.
- The health promotion program was delivered to 11 diverse student groups.
- All evaluators deemed the program beneficial and recommended it for other Qatari schools.
Conclusions:
- The developed health promotion program effectively addresses medication safety needs in schoolchildren.
- The program is suitable for implementation in primary schools across Qatar.
- This initiative serves as a model for similar programs in the Eastern Mediterranean Region and beyond.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
101
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
101
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:29Drug Dosing: Infants and Children
886
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
505
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
360
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360